Increased interaction between PACT molecules in response to stress signals is required for PKR activation

Journal of Cellular Biochemistry

Volumn 113, Issue 8, 2012, Pages 2754-2764

  Singh, Madhurima ^a   Patel, Rekha C ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

dsRBM; dsRNA; Interferon; Kinase; PACT; PKR

Indexed keywords

ALANINE; ASPARTIC ACID; ENZYME ACTIVATOR; ENZYME ACTIVATOR PACT; PROTEIN KINASE R; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; ENZYME ACTIVATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EIF-2 KINASE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; PHOSPHORYLATION; PROTEIN BINDING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84862517868     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24152     Document Type: Article

References (54)

1. Anderson E, Quartararo C, Brown RS, Shi Y, Yao X, Cole JL. 2010. Analysis of monomeric and dimeric phosphorylated forms of protein kinase R. Biochemistry 49:1217-1225.
2. Benkirane M, Neuveut C, Chun RF, Smith SM, Samuel CE, Gatignol A, Jeang KT. 1997. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J 16:611-624. (Pubitemid 27067790)
3. Bennett RL, Blalock WL, Abtahi DM, Pan Y, Moyer SA, May WS. 2006. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection. Blood 108:821-829. (Pubitemid 44154613)
4. Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, Abbruzzese A. 2004. Alpha-interferon and its effects on signalling pathways within cells. Curr Protein Pept Sci 5:475-485. (Pubitemid 39549432)
5. Caraglia M, Marra M, Tagliaferri P, Lamberts SW, Zappavigna S, Misso G, Cavagnini F, Facchini G, Abbruzzese A, Hofland LJ, Vitale G. 2009. Emerging strategies to strengthen the anti-tumour activity of type I interferons: Overcoming survival pathways. Curr Cancer Drug Targets 9:690-704.
6. Chang KY, Ramos A. 2005. The double-stranded RNA-binding motif, a versatile macromolecular docking platform. FEBS J 272:2109-2117. (Pubitemid 40646782)
7. Cole JL. 2007. Activation of PKR: An open and shut case? Trends Biochem Sci 32:57-62. (Pubitemid 46199193)
8. Coolidge CJ, Patton JG. 2000. A new double-stranded RNA-binding protein that interacts with PKR. Nucleic Acids Res 28:1407-1417. (Pubitemid 30142684)
9. Cosentino GP, Venkatesan S, Serluca FC, Green SR, Mathews MB, Sonenberg N. 1995. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci USA 92:9445-9449.
10. Daher A, Longuet M, Dorin D, Bois F, Segeral E, Bannwarth S, Battisti PL, Purcell DF, Benarous R, Vaquero C, Meurs EF, Gatignol A. 2001. Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J Biol Chem 276:33899-33905.
11. Daher A, Laraki G, Singh M, Melendez-Pena CE, Bannwarth S, Peters AH, Meurs EF, Braun RE, Patel RC, Gatignol A. 2009. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol Cell Biol 29:254-265.
12. Daniels SM, Melendez-Pena CE, Scarborough RJ, Daher A, Christensen HS, El Far M, Purcell DF, Laine S, Gatignol A. 2009. Characterization of the TRBP domain required for dicer interaction and function in RNA interference. BMC Mol Biol 10:38.
13. Erdmann J, Vitale G, van Koetsveld PM, Croze E, Sprij-Mooij DM, Hofland LJ, van Eijck CH. 2011. Effects of interferons alpha/beta on the proliferation of human micro- and macrovascular endothelial cells. J Interferon Cytokine Res 31:451-458.
14. Garcia MA, Collado M, Munoz-Fontela C, Matheu A, Marcos-Villar L, Arroyo J, Esteban M, Serrano M, Rivas C. 2006a. Antiviral action of the tumor suppressor ARF. Embo J 25:4284-4292. (Pubitemid 44435226)
15. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M. 2006b. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032-1060. (Pubitemid 44958263)
16. Green SR, Mathews MB. 1992. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev 6:2478-2490. (Pubitemid 23052877)
17. Heinicke LA, Wong CJ, Lary J, Nallagatla SR, Diegelman-Parente A, Zheng X, Cole JL, Bevilacqua PC. 2009. RNA dimerization promotes PKR dimerization and activation. J Mol Biol 390:319-338.
18. Hiraguri A, Itoh R, Kondo N, Nomura Y, Aizawa D, Murai Y, Koiwa H, Seki M, Shinozaki K, Fukuhara T. 2005. Specific interactions between Dicer-like proteins and HYL1/DRB-family dsRNA-binding proteins in Arabidopsis thaliana. Plant Mol Biol 57:173-188. (Pubitemid 40572925)
19. Hitti EG, Sallacz NB, Schoft VK, Jantsch MF. 2004. Oligomerization activity of a double-stranded RNA-binding domain. FEBS Lett 574:25-30. (Pubitemid 39200889)
20. Hovanessian AG, Galabru J. 1987. The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur J Biochem 167:467-473. (Pubitemid 17129999)
21. Huang X, Hutchins B, Patel RC. 2002. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem J 366:175-186. (Pubitemid 34971816)
22. Ito T, Yang M, May WS. 1999. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 274:15427-15432.
23. Laraki G, Clerzius G, Daher A, Melendez-Pena C, Daniels S, Gatignol A. 2008. Interactions between the double-stranded RNA-binding proteins TRBP and PACT define the Medipal domain that mediates protein-protein interactions. RNA Biol 5:92-103. (Pubitemid 351881377)
24. Lee JY, Kim H, Ryu CH, Kim JY, Choi BH, Lim Y, Huh PW, Kim YH, Lee KH, Jun TY, Rha HK, Kang JK, Choi CR. 2004. Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem 279:30265-30273. (Pubitemid 38937953)
25. Lemaire PA, Lary J, Cole JL. 2005. Mechanism of PKR activation: Dimerization and kinase activation in the absence of double-stranded RNA. J Mol Biol 345:81-90. (Pubitemid 39572826)
26. Lemaire PA, Anderson E, Lary J, Cole JL. 2008. Mechanism of PKR Activation by dsRNA. J Mol Biol 381:351-360.
27. Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC. 2006. Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci USA 103:10005-10010. (Pubitemid 43993613)
28. Li YJ, Zeng JM, Huang SF, Wang XZ, Zhao SQ, Bai WJ, Cao WX, Huang ZG, Feng WL. 2011. Selective leukemia cell death by activation of the double-stranded RNA-dependent protein kinase PKR. Int J Mol Med 28:215-222.
29. McCormack SJ, Thomis DC, Samuel CE. 1992. Mechanism of interferon action: Identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. Virology 188:47-56.
30. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
31. Mittelstadt M, Frump A, Khuu T, Fowlkes V, Handy I, Patel CV, Patel RC. 2008. Interaction of human tRNA-dihydrouridine synthase-2 with interferon-induced protein kinase PKR. Nucleic Acids Res 36:998-1008. (Pubitemid 351267253)
32. Nanduri S, Rahman F, Williams BR, Qin J. 2000. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J 19:5567-5574.
33. Park H, Davies MV, Langland JO, Chang HW, Nam YS, Tartaglia J, Paoletti E, Jacobs BL, Kaufman RJ, Venkatesan S. 1994. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc Natl Acad Sci USA 91:4713-4717. (Pubitemid 24177719)
34. Paroo Z, Ye X, Chen S, Liu Q. 2009. Phosphorylation of the human micro-RNA-generating complex mediates MAPK/Erk signaling. Cell 139:112-122.
35. Patel RC, Sen GC. 1992. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J Biol Chem 267:7671-7676.
36. Patel RC, Sen GC. 1998a. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 17:4379-4390. (Pubitemid 28362628)
37. Patel RC, Sen GC. 1998b. Requirement of PKR dimerization mediated by specific hydrophobic residues for its activation by double-stranded RNA and its antigrowth effects in yeast. Mol Cell Biol 18:7009-7019. (Pubitemid 28533021)
38. Patel RC, Stanton P, McMillan NM, Williams BR, Sen GC. 1995. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc Natl Acad Sci USA 92:8283-8287.
39. Patel CV, Handy I, Goldsmith T, Patel RC. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275:37993-37998. (Pubitemid 32004921)
40. Peters GA, Hartmann R, Qin J, Sen GC. 2001. Modular structure of PACT: Distinct domains for binding and activating PKR. Mol Cell Biol 21:1908-1920. (Pubitemid 32479615)
41. Peters GA, Li S, Sen GC. 2006. Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J Biol Chem 281:35129-35136. (Pubitemid 46036552)
42. Peters GA, Dickerman B, Sen GC. 2009. Biochemical analysis of PKR activation by PACT. Biochemistry 48:7441-7447.
43. Poulsen H, Jorgensen R, Heding A, Nielsen FC, Bonven B, Egebjerg J. 2006. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA 12:1350-1360. (Pubitemid 43990559)
44. Robertson HD, Mathews MB. 1996. The regulation of the protein kinase PKR by RNA. Biochimie 78:909-914. (Pubitemid 27193109)
45. Samuel CE. 1993. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 268:7603-7606. (Pubitemid 23120319)
46. Singh M, Castillo D, Patel CV, Patel RC. 2011. Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. Biochemistry 50:4550-4560.
47. Singh M, Fowlkes V, Handy I, Patel CV, Patel RC. 2009. Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis. J Mol Biol 385:457-468.
48. St Johnston D, Brown NH, Gall JG, Jantsch M. 1992. A conserved double-stranded RNA-binding domain. Proc Natl Acad Sci USA 89:10979-10983.
49. Taylor SS, Haste NM, Ghosh G. 2005. PKR and eIF2alpha: Integration of kinase dimerization, activation, and substrate docking. Cell 122:823-825. (Pubitemid 41345196)
50. Vattem KM, Staschke KA, Zhu S, Wek RC. 2001. Inhibitory sequences in the N-terminus of the double-stranded-RNA-dependent protein kinase, PKR, are important for regulating phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha). Eur J Biochem 268:1143-1153. (Pubitemid 32328359)
51. Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M. 2012. The PPAR-gamma agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-beta treated pancreatic cancer cells. Biotechnol Adv 30:169-184.
52. Williams BR. 2001. Signal integration via PKR. Sci STKE 2001:RE2.
53. Williams BRG. 1995. The role of the dsRNA-activated kinase, PKR, in signal transduction. Semin Virol 6:191-202.
54. Zhang F, Romano PR, Nagamura-Inoue T, Tian B, Dever TE, Mathews MB, Ozato K, Hinnebusch AG. 2001. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem 276:24946-24958.